Diffusion-weighted magnetic resonance imaging of breast lesions: First Experiences at 3 T

Journal of Computer Assisted Tomography

Volumn 33, Issue 1, 2009, Pages 63-69

  Lo, Gladys G ^a   Ai, Victor ^a   Chan, John K F ^a   Li, K W ^a   Cheung, Polly S Y ^a   Wong, T T ^a   Ma, Micheal ^a   Lee, Raymond ^a   Chien, Daisy ^a  

^a HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

3 T; Breast; Diffusion; Diffusion weighted imaging; MRI

Indexed keywords

BIOPSY; MAMMOGRAPHY; SURFACE DIFFUSION; ULTRASONIC APPLICATIONS;

3 T; APPARENT DIFFUSION COEFFICIENT; BREAST; BREAST CANCER; BREAST LESION; COEFFICIENT MEASUREMENT; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; DIFFUSION-WEIGHTED MAGNETIC RESONANCE; DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING;

MAGNETIC RESONANCE IMAGING;

ADULT; ARTICLE; BENIGN TUMOR; BREAST LESION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EXCISION; EXPERIENCE; FEMALE; HISTOLOGY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MAMMOGRAPHY; NEEDLE BIOPSY; PREDICTOR VARIABLE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ULTRASOUND; AGED; BREAST TUMOR; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; PILOT STUDY; REPRODUCIBILITY;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; AGED; BREAST NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; MIDDLE AGED; OBSERVER VARIATION; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 62149114870     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e318165dc6b     Document Type: Article

References (30)

1. Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology. 1995;196:115-122.
2. Orel SG, Schnall MD, LiVolsi VA, et al. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology. 1994;190:485-493.
3. Harms SE, Flamig DP. MR imaging of the breast. J Magn Reson Imaging. 1993;3:277-283.
4. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology. 1994;193:777-781.
5. Heywang SH. Contrast enhanced magnetic resonance imaging of the breast. Invest Radiol. 1994;29:94-104.
6. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA - preliminary observations. Radiology. 1989;170:681-686.
7. Heiberg EV, Perman WH, Herrmann VM, et al. Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. Magn Reson Imaging. 1996;14:337-348.
8. Flickinger FW, Allison JD, Sherry RM, et al. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magn Reson Imaging. 1993;11:617-620.
9. Schelfort K, Van Goethem M, Kersschot E, et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol. 2004;30:501-507.
10. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292:1317-1325.
11. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469-8476.
12. Kuhl CK, Kuhn W, Schild H. Management of women at high risk for breast cancer: new imaging beyond mammography. Breast. 2005;14:480-486.
13. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, et al. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat. 2000;63:53-60.
14. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427-437.
15. Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet. 2005;365:1769-1778.
16. Kaiser WA, Mittelmeier O. MR mammography in patients at risk [in German]. RöFo, Fortschr. Geb. Röntgenstrahlen Neuen Bildgeb. Verfahr. 1992;156:576-581.
17. Siegmann KC, Muller-Schimpfle M, Schick F, et al. MR imaging-detected breast lesions: histopathologic correlation of lesion characteristics and signal intensity data. AJR Am J Roentgenol. 2002;178:1403-1409.
18. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging. 2002;16:172-178.
19. Kinoshita T, Yashiro N, Ihara N, et al. Diffusion-weighted half-Fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J Comput Assist Tomogr. 2002;26:1042-1046.
20. Woodhams R, Matsunaga K, Iwabuchi R, et al. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr. 2005;29:644-649.
21. Warach S, Chien D, Li W, et al. Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology. 1992;42:1717-1723.
22. Ichikawa T, Haradome H, Hachiya J, et al. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol. 1998;170:397-402.
23. Theilmann RJ, Borders R, Trouard TP, et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia. 2004;6:831-837.
24. Yamashita Y, Namimoto T, Mitsuzaki K, et al. Mucin-producingtumor of the pancreas: diagnostic value of diffusion-weighted echo-planar MR imaging. Radiology. 1998;208:605-609.
25. Moteki T, Ishizaka H. Diffusion-weighted EPI of cystic ovarian lesions: evaluation of cystic contents using apparent diffusion coefficients. J Magn Reson Imaging. 2000;12:1014-1019.
26. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology. 1997;203:137-144.
27. Muller-Schimpfle M, Ohmenhauser K, Stoll P, et al. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology. 1997;203:145-149.
28. Charles-Edwards EM, de Souza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging. 2006;6:135-143.
29. Partridge SC, McKinnon GC, Henry RG, et al. Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI. J Magn Reson Imaging. 2001;14:433-438.
30. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology. 1996;200:639-649.